PAX6 and glioblastoma: Further, they also showed reduced expression of its onco-suppressor target paired box 6 (PAX6); GBM tissues also showed increased miR-223 and reduced PAX6 expression compared to control tissues during an immunohistochemical characterization on a tissue microarray [192].